Management Strategies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Summary

Hepatocellular carcinoma complicated by portal vein tumour thrombus (PVTT) represents an advanced stage of liver malignancy with a historically poor prognosis. Management demands a multidisciplinary approach tailored to tumour burden, thrombus extent and underlying liver function. Surgical resection remains an option for carefully selected patients, particularly those with limited PVTT and preserved hepatic reserve. Neoadjuvant regional therapies such as hepatic arterial infusion chemotherapy (HAIC) may downstage thrombus and improve post-operative survival. Locoregional modalities, including transarterial procedures and advanced radiotherapy techniques, offer local control and potential conversion to curative treatment. Systemic agents, notably multikinase inhibitors and combination immunotherapies, have extended survival in unresectable cases and are increasingly integrated with local treatments. Current strategies emphasise personalised sequencing and combination of surgery, regional therapy and systemic treatment to prolong overall survival, maintain quality of life and expand curative opportunities.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Management Strategies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus publication trend

The graph below shows the total number of articles in management strategies for hepatocellular carcinoma with portal vein tumor thrombus across all publications each year (not limited to Nature Index journals).

Technical terms

Hepatocellular carcinoma (HCC): The most common primary cancer of the liver, originating from hepatocytes.

Portal vein tumour thrombus (PVTT): Extension of malignant cells into the portal venous system, signifying vascular invasion and advanced disease.

Hepatic arterial infusion chemotherapy (HAIC): Administration of chemotherapeutic agents directly into the hepatic artery to concentrate therapy within the liver and associated thrombus.

Intensity-modulated radiotherapy (IMRT): A precision external-beam radiation technique that shapes dose distribution to maximise tumour irradiation while sparing normal tissue.

References

  1. Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study. Frontiers in Immunology (2023).
  2. Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus. Frontiers in Pharmacology (2023).
  3. Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Cancers (2023).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.